C92.20
Billable
Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission
C92.20 is billable and can be used for reimbursement purposes.
AI Search
Analyze diagnoses and doctors notes
Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission
C92.20 is billable and can be used for reimbursement purposes.